Enrollment open for new chordoma clinical trial
Chordoma patients with advanced or metastatic chordoma may soon be eligible to enroll in a new clinical trial testing the FDA-approved cancer drug cetuximab. Continue reading
Chordoma patients with advanced or metastatic chordoma may soon be eligible to enroll in a new clinical trial testing the FDA-approved cancer drug cetuximab. Continue reading
In the ten months since the U.S. Food and Drug Administration (FDA) lifted the partial clinical hold it placed on … Continue reading
We are excited to share a promising milestone in the Foundation-supported Phase 2 BN-Brachyury trial. Yesterday, we received confirmation from … Continue reading
Launched last summer, a Phase 2 clinical trial testing the effectiveness of the targeted therapy afatinib is continuing to enroll … Continue reading
Clinicians at Massachusetts General Hospital are now enrolling patients in a new Phase 2 clinical trial sponsored by biotechnology company … Continue reading
This is a derivative of “Leiden University Medical Center” by Dmflan and is licensed under CC BY 3.0 A new Phase … Continue reading
Launched last spring, a Phase 1 clinical trial studying the safety and initial effectiveness of the immunotherapy drug nivolumab with and … Continue reading
Thanks to the robust scientific infrastructure built by the Chordoma Foundation over the last decade, chordoma research is thriving. With … Continue reading
A new clinical trial has opened for chordoma patients with locally advanced or metastatic tumors testing the effectiveness of a … Continue reading
Please accept marketing-cookies to watch this video. Watch this video on YouTube » As the youngest child in a family … Continue reading